Merz North America, Inc. | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug information and related clinical trials

Explore a comprehensive list of organizations, including their profiles and details.

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

DeepMed Research

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 47 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "Merz North America, Inc."?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

Phase 4

Completed

Conditions: Tinea Cruris
Tinea Pedis

Interventions: Drug: NAFT600 (pediatric)
Drug: NAFT600 (adult)
Drug: NAFT500 (pediatric)
Drug: NAFT500 (adult)

First Posted Date: 2012-10-23

Last Posted Date: 2016-07-14

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 56

Registration Number: NCT01712360

Locations: 🇺🇸
Merz Investigative Site #001261, College Station, Texas, United States
🇩🇴
Merz Investigative Site #180001, Santo Domingo, Dominican Republic
🇭🇳
Merz Investigative Site #504001, San Pedro Sula, Honduras

and more 1 locations

Study of the Cabochon System for Improvement in the Appearance of Cellulite

Not Applicable

Completed

Conditions: Gynoid Lipodystrophy

Interventions: Device: Subcutaneous tissue release with the Cabochon System

First Posted Date: 2012-08-24

Last Posted Date: 2019-12-10

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 55

Registration Number: NCT01671839

Locations: 🇺🇸
Maryland Laser Skin & Vein Institute, Hunt Valley, Maryland, United States
🇺🇸
The Coleman Center for Cosmetic and Dermatologic Surgery, Metairie, Louisiana, United States
🇺🇸
SkinCare Physicians, Chestnut Hill, Massachusetts, United States

Belotero Post Approval Study

Phase 4

Completed

Conditions: Nasolabial Folds

Interventions: Device: Belotero®

First Posted Date: 2012-07-10

Last Posted Date: 2014-07-04

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 117

Registration Number: NCT01635855

Mederma to Reduce Appearance of Post Surgical Scars

Not Applicable

Completed

Conditions: Scars

Interventions: Other: Mederma N&I
Other: Mederma Ultra Gel

First Posted Date: 2012-01-05

Last Posted Date: 2013-10-24

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 20

Registration Number: NCT01504061

Locations: 🇺🇸
Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC, Charlotte, North Carolina, United States

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Phase 3

Completed

Conditions: Tinea Pedis

Interventions: Drug: NAFT-600 (naftin 2 % gel)
Drug: Placebo

First Posted Date: 2011-02-07

Last Posted Date: 2013-09-26

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 860

Registration Number: NCT01290341

Locations: 🇺🇸
Research Across America, Dallas, Texas, United States
🇺🇸
Clinical Research Atlanta, Stockbridge, Georgia, United States
🇺🇸
Hudson Dermatology, Evansville, Indiana, United States

and more 19 locations

Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Phase 3

Completed

Conditions: Tinea Pedis

Interventions: Drug: Placebo
Drug: NAFT-600 ( naftin 2 % gel )

First Posted Date: 2011-02-03

Last Posted Date: 2013-09-26

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 855

Registration Number: NCT01289015

Locations: 🇺🇸
International Dermatology Research, Inc., Miami, Florida, United States
🇺🇸
Northwest Clinical Trials, Boise, Idaho, United States
🇺🇸
UCSF Dermatology Research, San Francisco, California, United States

and more 20 locations

Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States

Completed

Conditions: Cervical Dystonia
Blepharospasm

Interventions: Biological: Xeomin®

First Posted Date: 2011-02-01

Last Posted Date: 2015-04-10

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 688

Registration Number: NCT01287247

Locations: 🇺🇸
Site #001979, Virginia Beach, Virginia, United States
🇺🇸
Merz Investigative Site #001986, Los Angeles, California, United States
🇺🇸
Site # 001972, Chicago, Illinois, United States

and more 66 locations

Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds

Not Applicable

Completed

Conditions: Nasolabial Folds

Interventions: Device: Radiesse® Injectable Dermal Filler without Lidocaine
Device: Radiesse® Injectable Dermal Filler with Lidocaine

First Posted Date: 2010-02-17

Last Posted Date: 2018-05-30

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 102

Registration Number: NCT01069354

Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler

Phase 4

Completed

Conditions: Nasolabial Folds

Interventions: Device: Radiesse® Injectable Dermal Filler Mixed with Lidocaine
Device: Radiesse® Injectable Dermal Filler without Lidocaine

First Posted Date: 2009-11-13

Last Posted Date: 2013-04-26

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 50

Registration Number: NCT01012661

Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color

Phase 4

Completed

Conditions: Nasolabial Folds

Interventions: Device: Radiesse® Injectable Dermal Filler

First Posted Date: 2009-11-13

Last Posted Date: 2013-04-26

Lead Sponsor: Merz North America, Inc.

Target Recruit Count: 100

Registration Number: NCT01012388

Prev
1
2
3
4
5
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy